Assess the Safety of a Microneedle Patch Tender in USA - 138576106

Procurement Summary

Country: USA

Summary: Assess the Safety of a Microneedle Patch for Vaccination against Rotavirus when Given Intradermally for Four 4 Administrations in Rats

Deadline: 09 Apr 2026

Posting Date: 27 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 138576106

Document Ref. No.: CDC-75D301-Presolicitation-SMNVARRATS

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Centers for Disease Control and Prevention (CDC) National Center for Immunizations and Respiratory Diseases (NCIRD) intends to award a Firm Fixed Price Contract to Southern Research Institute, 2000 9th Avenue S; Birmingham, Alabama 35205. Under the authority of FAR 13.106-1(b)(1)(i) and 10 U.S.C. 2304(c) (1), only one responsible source and no other supplies or services will satisfy agency requirements. The objectives of this project will be to assess the safety of an Live Attenuated Rotavirus Vaccine (LARV) Microneedle (MN) patch for vaccination against rotavirus when given intradermally for four (4) administrations in rats in accordance with regulatory requirements.
The Period of Performance is from 5/15/2026 thru 05/14/2028.
The anticipated award date of this action is on or before May 15, 2026. The applicable NAICS code is 541715: Research and Development In The Physical, Engineering And Life Sciences (Except Nanotechnology And Biotechnology). This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the warranties and proof as being capable of providing the requesting services. Capability Statements shall not exceed 2 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the d...
Notice ID: cdc-75d301-presolicitation-smnvarrats

Department/Ind. Agency: health and human services, department of

Sub-tier: centers for disease control and prevention

Office: cdc office of acquisition services

Product Service Code: b599 - special studies/analysis- other

NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Inactive Dates: apr 24, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice